Electromed (ELMD) Cash from Investing Activities (2010 - 2026)
Electromed (ELMD) posted quarterly Cash from Investing Activities of -$154000.0 for Q1 2026, down 205.48% year-over-year from $146000.0 in Q1 2025, and up 76.52% quarter-over-quarter from -$656000.0 in Q4 2025.
Electromed (ELMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Electromed (ELMD) has reported Cash from Investing Activities for 17 consecutive years, with -$154000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 205.48% year-over-year to -$154000.0; the TTM figure through Mar 2026 stood at -$1.2 million (down 532.82% YoY), while the FY2025 annual figure was -$306000.0, up 22.53% from the prior year.
- Cash from Investing Activities improved to -$154000.0 in Q1 2026 per ELMD's latest filing, from -$656000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $146000.0 in Q1 2025 and bottomed at -$656000.0 in Q4 2025.
- Historically, Cash from Investing Activities has averaged -$261117.6 across 5 years, with a median of -$237000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 659.38% — and 2025, when it jumped 213.18%.
- Electromed's Cash from Investing Activities stood at -$461000.0 in 2022, then surged by 81.13% to -$87000.0 in 2023, then slumped by 172.41% to -$237000.0 in 2024, then plunged by 176.79% to -$656000.0 in 2025, then surged by 76.52% to -$154000.0 in 2026.
- Business Quant data shows ELMD's Cash from Investing Activities at -$154000.0 in Q1 2026, -$656000.0 in Q4 2025, and -$267000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Electromed | 330.05 Mn | 313.06 Mn | 14.64 Mn | -154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -154,000.00 |
| Mar 31, 2026 | -154,000.00 |
| Dec 31, 2025 | -656,000.00 |
| Dec 31, 2025 | -656,000.00 |
| Sep 30, 2025 | -267,000.00 |
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -157,000.00 |
| Jun 30, 2025 | -157,000.00 |
| Mar 31, 2025 | 146,000.00 |
| Mar 31, 2025 | 146,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Jun 30, 2024 | -46,000.00 |
| Jun 30, 2024 | -46,000.00 |
| Mar 31, 2024 | -129,000.00 |
| Mar 31, 2024 | -129,000.00 |
| Dec 31, 2023 | -87,000.00 |
| Dec 31, 2023 | -87,000.00 |